Novartis India Limited Stock

Equities

NOVARTIND

INE234A01025

Pharmaceuticals

Market Closed - Bombay S.E. 06:16:37 2024-05-17 EDT 5-day change 1st Jan Change
1,102 INR +3.71% Intraday chart for Novartis India Limited +3.38% +42.55%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 4B 48.02M 65.38M Sales 2023 3.79B 45.49M 61.93M Capitalization 13.96B 168M 228M
Net income 2022 -37M -444K -605K Net income 2023 1.03B 12.42M 16.91M EV / Sales 2022 2.41 x
Net cash position 2022 4.92B 59.12M 80.49M Net cash position 2023 5.33B 64M 87.14M EV / Sales 2023 2.28 x
P/E ratio 2022
-392 x
P/E ratio 2023
13.5 x
Employees 67
Yield 2022
1.69%
Yield 2023
1.77%
Free-Float 27.17%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.71%
1 week+3.38%
Current month+6.49%
1 month+6.56%
3 months+6.45%
6 months+58.55%
Current year+42.55%
More quotes
1 week
1 025.00
Extreme 1025
1 116.55
1 month
991.00
Extreme 991
1 116.55
Current year
768.60
Extreme 768.6
1 224.00
1 year
599.95
Extreme 599.95
1 224.00
3 years
554.00
Extreme 554
1 224.00
5 years
420.05
Extreme 420.05
1 224.00
10 years
420.05
Extreme 420.05
1 224.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 22-04-30
Comptroller/Controller/Auditor - -
Members of the board TitleAgeSince
Director/Board Member 64 20-06-21
Chairman - 08-07-31
Director/Board Member 71 16-04-18
More insiders
Date Price Change Volume
24-05-17 1,102 +3.71% 35,478
24-05-16 1,063 +0.60% 12,980
24-05-15 1,057 +0.58% 9,832
24-05-14 1,050 +0.68% 9,029
24-05-13 1,043 -2.14% 52,985

Delayed Quote Bombay S.E., May 17, 2024 at 06:16 am

More quotes
Novartis India Limited is an India-based company that is engaged in the business of trading of pharmaceuticals. The Company's portfolio of medicines addresses various therapeutic needs, such as cardiovascular, eye care, immunology, metabolic, neuroscience, oncology, respiratory and organ transplant, to meet the medical needs of patients in India. In the bone and pain therapeutic area its brand is Voveran. In the transplantation immunology therapeutic area, the Company's brands include Simulect, Certican, Sandimmun, Neoral and Myfortic. In the neurosciences therapeutic area, its brands include Tegrital and Exelon.
More about the company
  1. Stock Market
  2. Equities
  3. NOVARTIND Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW